Company profile
Mosaic ImmunoEngineering Inc.
OTC: CPMV · Healthcare · Biotechnology
#1 of 1,418 Healthcare companies by revenue
EA Score
——FH 2DQ —GM —SS 37
v0.1 · 35/100 weight · pillars only
↑ listing tenure, market scale · ↓ balance-sheet leverage, Piotroski F
Methodology →Revenue TTM
$0
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
-$687.8k
Employees
7
as of 2026-08-23
Market cap
$441.8k
as of 2026-08-23
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Net income-$687.8k-$687.8k2025
Operating income-$616.1k-$616.1k2025
Total assets$19.9k$19.9k2025
Liabilities$7.5M$7.5M2025
Equity-$7.5M-$7.5M2025
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Mosaic ImmunoEngineering Inc.’s financial profile?
Mosaic ImmunoEngineering Inc. earned -$687.8k in FY2025 net income.
Peers · Healthcare
Canopus Biopharma, Inc.——OJsys, Inc.——PPJ Healthcare Enterprises, Inc.——Halberd Corporation——IM Cannabis Corp.——Southern Home Medical, Inc.——Neighbors
Orange →Key facts
CEOSteven W. King
SectorHealthcare
IndustryBiotechnology
HeadquartersHuntington Beach, CA
ExchangeOTC: CPMV
Employees7
IPO date2013-01-02
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.